Articles

Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients

Department of Paediatric Haematology and Oncology, Registre National des Neutropénies Chroniques, AP-HP Trousseau Hospital, Paris, France
Department of Paediatric Haematology and Immunology, CHU Toulouse, France
Department of Clinical Immunology Assistance Publique – Hôpitaux de Paris (AP-HP) Saint-Louis Hospital, France;INSERM UMR1126, Centre Hayem, Université Paris Denis Diderot, Sorbonne Paris Cité, France
Department of Haematology and Bone Marrow Transplantation, AP-HP Saint-Louis Hospital, Paris, France
Genetic Laboratory, AP-HP Robert Debré Hospital, Paris, France
Department of Haematology, AP-HP Robert Debré Hospital, Paris, France
French Neutropenia Registry, AP-HP Trousseau Hospital, Paris, France
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Necker-Enfants Malades Hospital, Paris, France;Centre for the Study of Primary Immunodeficiencies, Necker-Enfants Malades Hospital, AP-HP, Paris, France;St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, New York, NY, USA;Paris Descartes University, Imagine Institute, Paris, France
Centre for Human Genetics, Cliniques Universitaires Saint-Luc & Human Molecular Genetics (GEHU), de Duve Institute -Université Catholique de Louvain, Brussels, Belgium
Department of Genetics, CHU Nantes, France
Department of Haematology, St Luc Hospital, Brussels, Belgium
Department of Internal Medicine, CHU Nantes, France
Department of Haematology, CHU de Rennes, France
Department of Paediatric Haematology and Oncology, CHU de Rennes, France
Department of Paediatric Haematology, CHU de Marseille, Hopital La Timone, Université Aix-Marseille, France
Internal Medicine, CHU de Marseille, Hopital La Timone, Université Aix-Marseille, France
Department of Haematology, AP-HP Robert Debré Hospital, Paris, France
Department of Haematology, CHU de Besançon, France
Department of Haematology, AP-HP Necker-Enfants Malades, INSERM UMR 1163 and CNRS ERL 8254 Institut Imagine, Sorbonne Paris Cité, Université Paris Descartes, France
Department of Haematology, CHU de Nancy, France
Department of Paediatric Haematology, CHU de Lille, France
Department of Paediatric Haematology, CHU de Lille, France
Department of Internal Medicine and Immunology, CHU Lille, France
Department of Haematology, CHU d’Angers, France
Department of Haematology, CHU de Strasbourg, France
Department of Neurology, Hôpitaux Civils de Colmar, France
Inflammation Chimiokines et Immunopathologie, INSERM, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, Clamart, France
Laboratory of Haematology, CHU de Lille, France
Laboratory of Haematology, IUCT-Oncopole, Toulouse, France;Centre of Research in Oncology, INSERM U1037, Team 16, IUCT-Oncopole, Toulouse, France
Genetic Laboratory, AP-HP Robert Debré Hospital, Paris, France
Department of Genetics, AP-HP Pitié Salpêtrière Hospital, Faculté de Médecine Sorbonne Université, Paris, France
Department of Paediatric Haematology and Immunology, CHU Toulouse, France;Centre of Research in Oncology, INSERM U1037, Team 16, IUCT-Oncopole, Toulouse, France
Vol. 103 No. 8 (2018): August, 2018 https://doi.org/10.3324/haematol.2017.181909